InvestorsHub Logo
Followers 4
Posts 324
Boards Moderated 0
Alias Born 08/20/2010

Re: None

Wednesday, 08/03/2011 12:05:35 PM

Wednesday, August 03, 2011 12:05:35 PM

Post# of 801
FDA approval news will change the game ..
It is anticipated that a 510(k) application will be filed with the FDA
in approximately 90 days. Assuming no extended delays in FDA review,
approval of Altrazeal® exSALT(TM) could occur as early as the third
quarter of 2011. The antimicrobial segment of the North American
advanced wound care market is projected to grow in the next 5 years to
be in excess of $750 million with annual growth rates above 15%.

http://www.redorbit.com/news/health/1981422/uluru_inc_announces_agree...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.